Background COVID-19 infection has been known to predispose patients to both arterial and
venous thromboembolic events such as deep venous thrombosis, pulmonary embolism …

Background and aims Initially, novel severe acute respiratory syndrome coronavirus (SARS-
CoV-2) was considered primarily a respiratory pathogen. However, with time it has behaved …

Importance Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare and
serious condition, has been described in Europe following receipt of the ChAdOx1 nCoV-19 …

The current pandemic caused by severe acute respiratory syndrome corona virus 2 (SARS-
CoV-2) is accompanied with a rapid increase of reports and papers detailing its neurological …

Background and objectives RCVS (Reversible Cerebral Vasoconstrictive Syndrome) is a
condition associated with vasoactive agents that alter endothelial function. There is growing …

Background and purpose The aim was to provide insights to the characteristics of headache
in the context of COVID‐19 on behalf of the Headache Scientific Panel and the Neuro …

Neurological and neuroradiological manifestations in patients with COVID-19 have been
extensively reported. Available imaging data are, however, very heterogeneous. Hence …

Background and Purpose Recent studies suggested an increased incidence of cerebral
venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We …

COVID-19 is primarily classified as a respiratory disorder; however, various neurological
symptoms have been reported in COVID-19 patients. Neurological manifestations may be …

Introduction: Previous reports and meta-analyses derived from small case series reported a
mortality rate of up to 40% in patients with coronavirus disease 2019 associated cerebral …